In liquidation · Vrijwillige ontbinding – vereffening (CBE)
QUALIBLOOD logo

QUALIBLOOD

BE0684698353

Rechtspersoon Public limited company 1 establishment

QUALIBLOOD is a research organisation in Liège. Public Limited, started on 15 November 2017, 1 establishment.

Rue Louvrex 55-57, 4000 Liège qualiblood.eu [email protected]

Start date

15 November 2017

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2023 and 2024.

  • Busy address KBO

    20 other companies have their registered office at the same address; threshold 10.

  • Legal situation KBO

    Vrijwillige ontbinding – vereffening according to the CBE.

Financials

Financial year 2024

QUALIBLOOD from Liège, company number BE0684698353, closed financial year 2024 with a result of € -560,095 after tax. For that financial year QUALIBLOOD recorded a gross margin of € -251,401 and equity of € 847,118. Compared with financial year 2023, the result moved from € -464,022 to € -560,095. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 7, 2025.

What it is worth Growing

€ 847,118

▲ € 660,593 vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -560,095

▼ 21 % more loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 199,551

▼ 52% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -483,570.

People and assets in 2024

Full-time equivalents

6.6

▲ 0.5 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 394,296

▼ 4% vs 2023

€ 59,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 84,239

▼ 32% vs 2023

Of which on lease € 44,040.

Debts at end 2024

Bank debt ≈ 21 years to go

€ 1.1 million

▲ 89% vs 2023

€ 40,712 is repaid this year. At this pace the long-term loan is gone in ≈ 21 years.

Owed to suppliers

€ 222,048

▲ € 211,671 vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 62,817

▼ 3% vs 2023

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2021202220232024Change 2023 → 2024
Gross margin € 958,273 € 433,553 € 56,338 € -251,401 ▼ € 307,739
Profit after taxes € 455,467 € -132,024 € -464,022 € -560,095 ▼ € 96,073
Equity € 782,571 € 650,547 € 186,525 € 847,118 ▲ € 660,593
Total debts € 529,327 € 283,850 € 921,140 € 1,371,249 ▲ 49%
Cash € 750,590 € 86,994 € 418,137 € 199,551 ▼ 52%
Land & buildings € 34,159 € 59,703 € 106,685 € 100,906 ▼ 5%
Retained profit € 672,571 € 540,547 € 76,525 € -483,570 ▼ € 560,095
Dividend € 11,000 € 0 € 0 € 0
Bank debt € 163,792 € 125,299 € 576,081 € 1,086,123 ▲ 89%
Balance sheet total € 1,311,898 € 934,397 € 1,107,665 € 2,625,264 ▲ 137%
Employees (FTE) 6.8 7 6.1 6.6 ▲ 0.5

Key figures of QUALIBLOOD, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to QUALIBLOOD?

What happened at QUALIBLOOD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

QUALIBLOOD is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.

  • NOSHAQ PARTNERS stepped down as director. NBB
  • Jean-Michel FOIDART stepped down as director. NBB
  • CENTRE HOSPITALIER UNIVERSITAIRE DINANT GODINNE SAINTE-ELISABETH-UCL-NAMUR stepped down as director. NBB
  • Bernard MASEREEL stepped down as director. NBB
  • NAMUR INVEST stepped down as director. NBB
  • Conseils, Gestion, Organisation - C.G.O stepped down as director. NBB
  • New annual accounts for financial year 2024: loss of € 560,095. Source: NBB ↗
  • NOSHAQ PARTNERS became a director. NBB

In short

From € 455,467 profit in 2021 to € 560,095 loss in 2024.

Paid € 51,379 in corporate taxes since 2021.

Best year ever: 2021, with € 455,467 profit.

On average € 9,200 of value added per employee in 2023.

Management

Directors

According to the 2024 annual accounts

since 2024 · until 2030

Jean-Michel FOIDART

Director

since 2024 · until 2030

since 2024 · until 2030

Bernard MASEREEL

Director

Also active at: MEDIPHA

since 2024 · until 2030

since 2024 · until 2030

Conseils, Gestion, Organisation - C.G.O

Director · represented by Delaunois PHILIPPE

Also active at: GROTTES DE HAN, DEQUACHIM, EUROQUARTZ, DEQUALEX, DEQUENNE CHIMIE

since 2024 · until 2030

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Louvrex 55-57

4000 Liège

2.270.012.410

Boulevard de Patience et Beaujonc 3

4000 Liège

Active since 15 November 2017

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

AMPApacheBootstrapComplianzFont AwesomeGoogle AnalyticsGoogle MapsPHPSlickWP RocketWordPressYoast SEOYouTube EmbedjQueryjsDelivrlazysizes

Hosting & Email

Email provider

Microsoft 365

Hosting

PLANETHOSTER-8 - PlanetHoster, CA

Domain

Domain

qualiblood.eu

Registrar

PlanetHoster

Website info

HTTPS Ja
Languages EN
Copyright 2026

Features

Webshop

Security

✓ HTTPS
✓ SPF
✓ DMARC

Details

Company number
0684.698.353
VAT number
BE 0684.698.353
Registered office
Rue Louvrex 55-57, 4000 Liège
Names & denominations
QUALIBLOOD
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Vrijwillige ontbinding – vereffening
Start date
15 November 2017
Peppol
Active · Active since 31 Mar 2026
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Frequently asked questions

What does QUALIBLOOD do?
QUALIBLOOD is a research organisation in Liège. Public Limited, started on 15 November 2017, 1 establishment.
What is the address of QUALIBLOOD?
The registered office of QUALIBLOOD is located at Rue Louvrex 55-57, 4000 Liège.
Is QUALIBLOOD still active?
Not as usual. The CBE lists QUALIBLOOD with legal situation “Vrijwillige ontbinding – vereffening”.
Is QUALIBLOOD registered on Peppol?
Yes, QUALIBLOOD is registered on the Peppol network with ID 0208:0684698353.
What is the enterprise number of QUALIBLOOD?
The enterprise number of QUALIBLOOD is BE0684698353.
When was QUALIBLOOD founded?
QUALIBLOOD was founded on 15 November 2017.